Abbvie Stock News & Updates
[WKN: A1J84E | Symbol: ABBV]
US Stock Markets on the Rise – Geopolitical Relief Pressures Oil Prices – Giant Merger Between AstraZeneca and Bristol Myers Squibb in the Works – Chevron Shines with Record Profit and Strategic Pipeline Deal – AbbVie Lowers Forecast After Apogee Acquisition – ExxonMobil Misses Expectations Despite Billion-Dollar Profit – Alphabet Pulls AI Feature in Google Earth After Fake Images – Spider-Man Delivers Gigantic Record Weekend to Theaters
After the latest trading day on Friday, July 31, 2026, the US stock markets presented themselves in an...
Abbvie: How is a new Aesthetics Strategy Targeting Hesitant Patients?
The European Commission approved the neurotoxin Boey (trenibotulinumtoxinE) from Abbvie's subsidiary...
AbbVie: Apogee Deal and Cancer Success Fuel the Stock
Phase 3 data on Epcoritamab show an impressive reduction in disease progression in cancer medicine...
DAX remains stable at the start of the week - Nagarro soars after takeover bid - Infineon firm after positive analyst comments from HSBC and Barclays - Nordex in focus after US large order - Automotive sector weak again - ON Semiconductor under pressure after Synaptics acquisition - AbbVie in view following approval recommendation for Upadacitinib!
The DAX presents itself at the beginning of the week with slight gains. After a robust opening, the...
AbbVie on the Brink of Billion-Dollar Acquisition of Apogee Therapeutics! The Post-Humira Era is Taking Shape!
AbbVie is close to a $10.9 billion acquisition of Apogee Therapeutics to secure its core immunology...
US Markets Closed on Friday – Diplomatic Collapse and Hormuz Blockade in Middle East Poker – Toy Story 5 Saves Disney’s Box Office – L3Harris Delivers New President Jet in Record Time – AbbVie Nears Billion-Dollar Acquisition of Apogee Therapeutics – SpaceX Receives Catastrophic ESG Rating Before IPO – Microsoft CEO Nadella Calls for Radical AI Strategy Shift – ASML Under Pressure Due to Renewed US Sanction Concerns
The US stock markets remained closed on Friday, June 19, 2026, due to the Juneteenth National Independence...
Strong Market Jump in the US – Inflation Lower Than Expected – Hope for Three Rate Cuts – Trump Increases Pressure on Powell – Labor Market Report to Continue – Circle Raises USDC Circulation by 90% - Perplexity Offers $34.5 Billion for Chrome – CoreWeave Drops Despite Strong Revenue Increase – CAVA Significantly Misses Store Growth – Rigetti Presents Roadmap for 100 Qubit Systems – AbbVie Invests in US Production – eToro Benefits From Trading Boom
On Tuesday, August 12, 2025, the major US stock exchanges made a strong rebound. The Dow Jones gained...
Drug Revenues Higher Than Expected! AbbVie Soars and Raises Earnings Forecast for 2025!
The pharmaceutical company AbbVie (ABBV) announced its business figures for the 1st quarter of 2025 on...
Pharmaceutical Stocks are Gaining Momentum: The Defensive Winners of 2025
In times of increased market volatility, pharmaceutical stocks are experiencing a remarkable comeback....
Financially Strong Year-End: AbbVie Exceeds Expectations
AbbVie is a global biopharmaceutical company specializing in the research and development of drugs in...
- ‹
- 1
- ›